P41Women's health study of Mycoplasma genitalium: a feasibility study
BackgroundThe role of Mycoplasma genitalium ( similar to 3% prevalence in women) in PID is unclear. An opportunity exists to study its natural history since there are no UK treatment guidelines. We conducted a feasibility study.ObjectivesIn women attending GUM clinics to determine: (1) recruitment a...
Gespeichert in:
| Veröffentlicht in: | Sexually transmitted infections 2012-06, Vol.88 (Suppl 1), p.A23-A23 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | A23 |
|---|---|
| container_issue | Suppl 1 |
| container_start_page | A23 |
| container_title | Sexually transmitted infections |
| container_volume | 88 |
| creator | Dave, S Kerry, S R Oakeshott, P McGregor, F Cannon, E Stephenson, J M |
| description | BackgroundThe role of Mycoplasma genitalium ( similar to 3% prevalence in women) in PID is unclear. An opportunity exists to study its natural history since there are no UK treatment guidelines. We conducted a feasibility study.ObjectivesIn women attending GUM clinics to determine: (1) recruitment and follow-up rates after 3 and 6months, (2) feasibility of obtaining NHS numbers, (3) facilitators and barriers to follow-up.MethodsWomen aged 16-24years recruited from two GUM clinics completed a questionnaire and provided two self-taken vaginal samples. One sample was tested for chlamydia. We are testing for M genitalium and conducting 3-month follow-up.ResultsRecruitment rate was 67% (199/296). Non-responders were similar in age to responders (20.6 SD 2.5 vs 20.7 SD 2.5years) but more likely to come from ethnic minority groups: 56% (37/66) vs 36% (71/195), p |
| doi_str_mv | 10.1136/sextrans-2012-050601c.41 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_1551637856</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1551637856</sourcerecordid><originalsourceid>FETCH-proquest_miscellaneous_15516378563</originalsourceid><addsrcrecordid>eNqVyrFuwjAQAFAPVCJt-QdvsCT1xbEDXasgFiQGpI7RES6NKycGzpGav2eAH-j0lieEBJUBaPvB9BdvOHCaK8hTZZRV0GQFzEQCRZmnOrd6Ll6Zf5VStjSbRFSHAr5DT8OSZUfoYyc5judJhlbupyZcPHKP8ocGF9G7sf-UKFtCdifnXZwe-128tOiZFk_fxGpbHb926eUWriNxrHvHDXmPA4WRazAGrC7Xxup_1Dty50aW</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1551637856</pqid></control><display><type>article</type><title>P41Women's health study of Mycoplasma genitalium: a feasibility study</title><source>BMJ Journals - NESLi2</source><creator>Dave, S ; Kerry, S R ; Oakeshott, P ; McGregor, F ; Cannon, E ; Stephenson, J M</creator><creatorcontrib>Dave, S ; Kerry, S R ; Oakeshott, P ; McGregor, F ; Cannon, E ; Stephenson, J M</creatorcontrib><description>BackgroundThe role of Mycoplasma genitalium ( similar to 3% prevalence in women) in PID is unclear. An opportunity exists to study its natural history since there are no UK treatment guidelines. We conducted a feasibility study.ObjectivesIn women attending GUM clinics to determine: (1) recruitment and follow-up rates after 3 and 6months, (2) feasibility of obtaining NHS numbers, (3) facilitators and barriers to follow-up.MethodsWomen aged 16-24years recruited from two GUM clinics completed a questionnaire and provided two self-taken vaginal samples. One sample was tested for chlamydia. We are testing for M genitalium and conducting 3-month follow-up.ResultsRecruitment rate was 67% (199/296). Non-responders were similar in age to responders (20.6 SD 2.5 vs 20.7 SD 2.5years) but more likely to come from ethnic minority groups: 56% (37/66) vs 36% (71/195), p<0.05. Among responders, mean sexual debut age was 16.3years (range 12-23 n=198); 59% (116/195) reported greater than or equal to 2 sexual partners and 17% (31/186) consistently used condoms in the preceding 12months. 8.2% (16/197) had chlamydia and 0.5% (1/197) gonorrhoea on testing. At recruitment 196 participants consented to NHS numbers being obtained and used to access medical records; 197 participants agreed to 3-month follow-up. We have been able to contact similar to 50% of participants for follow-up.DiscussionMost women consented to NHS number and medical record access. This is important for investigating long-term sequelae of STIs. Fewer women took part in follow-up than agreed at recruitment. It is important to understand the reasons for this.</description><identifier>ISSN: 1472-3263</identifier><identifier>DOI: 10.1136/sextrans-2012-050601c.41</identifier><language>eng</language><subject>Chlamydia ; Mycoplasma genitalium</subject><ispartof>Sexually transmitted infections, 2012-06, Vol.88 (Suppl 1), p.A23-A23</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids></links><search><creatorcontrib>Dave, S</creatorcontrib><creatorcontrib>Kerry, S R</creatorcontrib><creatorcontrib>Oakeshott, P</creatorcontrib><creatorcontrib>McGregor, F</creatorcontrib><creatorcontrib>Cannon, E</creatorcontrib><creatorcontrib>Stephenson, J M</creatorcontrib><title>P41Women's health study of Mycoplasma genitalium: a feasibility study</title><title>Sexually transmitted infections</title><description>BackgroundThe role of Mycoplasma genitalium ( similar to 3% prevalence in women) in PID is unclear. An opportunity exists to study its natural history since there are no UK treatment guidelines. We conducted a feasibility study.ObjectivesIn women attending GUM clinics to determine: (1) recruitment and follow-up rates after 3 and 6months, (2) feasibility of obtaining NHS numbers, (3) facilitators and barriers to follow-up.MethodsWomen aged 16-24years recruited from two GUM clinics completed a questionnaire and provided two self-taken vaginal samples. One sample was tested for chlamydia. We are testing for M genitalium and conducting 3-month follow-up.ResultsRecruitment rate was 67% (199/296). Non-responders were similar in age to responders (20.6 SD 2.5 vs 20.7 SD 2.5years) but more likely to come from ethnic minority groups: 56% (37/66) vs 36% (71/195), p<0.05. Among responders, mean sexual debut age was 16.3years (range 12-23 n=198); 59% (116/195) reported greater than or equal to 2 sexual partners and 17% (31/186) consistently used condoms in the preceding 12months. 8.2% (16/197) had chlamydia and 0.5% (1/197) gonorrhoea on testing. At recruitment 196 participants consented to NHS numbers being obtained and used to access medical records; 197 participants agreed to 3-month follow-up. We have been able to contact similar to 50% of participants for follow-up.DiscussionMost women consented to NHS number and medical record access. This is important for investigating long-term sequelae of STIs. Fewer women took part in follow-up than agreed at recruitment. It is important to understand the reasons for this.</description><subject>Chlamydia</subject><subject>Mycoplasma genitalium</subject><issn>1472-3263</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNqVyrFuwjAQAFAPVCJt-QdvsCT1xbEDXasgFiQGpI7RES6NKycGzpGav2eAH-j0lieEBJUBaPvB9BdvOHCaK8hTZZRV0GQFzEQCRZmnOrd6Ll6Zf5VStjSbRFSHAr5DT8OSZUfoYyc5judJhlbupyZcPHKP8ocGF9G7sf-UKFtCdifnXZwe-128tOiZFk_fxGpbHb926eUWriNxrHvHDXmPA4WRazAGrC7Xxup_1Dty50aW</recordid><startdate>20120601</startdate><enddate>20120601</enddate><creator>Dave, S</creator><creator>Kerry, S R</creator><creator>Oakeshott, P</creator><creator>McGregor, F</creator><creator>Cannon, E</creator><creator>Stephenson, J M</creator><scope>7QL</scope><scope>C1K</scope></search><sort><creationdate>20120601</creationdate><title>P41Women's health study of Mycoplasma genitalium: a feasibility study</title><author>Dave, S ; Kerry, S R ; Oakeshott, P ; McGregor, F ; Cannon, E ; Stephenson, J M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_miscellaneous_15516378563</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Chlamydia</topic><topic>Mycoplasma genitalium</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dave, S</creatorcontrib><creatorcontrib>Kerry, S R</creatorcontrib><creatorcontrib>Oakeshott, P</creatorcontrib><creatorcontrib>McGregor, F</creatorcontrib><creatorcontrib>Cannon, E</creatorcontrib><creatorcontrib>Stephenson, J M</creatorcontrib><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Sexually transmitted infections</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dave, S</au><au>Kerry, S R</au><au>Oakeshott, P</au><au>McGregor, F</au><au>Cannon, E</au><au>Stephenson, J M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>P41Women's health study of Mycoplasma genitalium: a feasibility study</atitle><jtitle>Sexually transmitted infections</jtitle><date>2012-06-01</date><risdate>2012</risdate><volume>88</volume><issue>Suppl 1</issue><spage>A23</spage><epage>A23</epage><pages>A23-A23</pages><issn>1472-3263</issn><abstract>BackgroundThe role of Mycoplasma genitalium ( similar to 3% prevalence in women) in PID is unclear. An opportunity exists to study its natural history since there are no UK treatment guidelines. We conducted a feasibility study.ObjectivesIn women attending GUM clinics to determine: (1) recruitment and follow-up rates after 3 and 6months, (2) feasibility of obtaining NHS numbers, (3) facilitators and barriers to follow-up.MethodsWomen aged 16-24years recruited from two GUM clinics completed a questionnaire and provided two self-taken vaginal samples. One sample was tested for chlamydia. We are testing for M genitalium and conducting 3-month follow-up.ResultsRecruitment rate was 67% (199/296). Non-responders were similar in age to responders (20.6 SD 2.5 vs 20.7 SD 2.5years) but more likely to come from ethnic minority groups: 56% (37/66) vs 36% (71/195), p<0.05. Among responders, mean sexual debut age was 16.3years (range 12-23 n=198); 59% (116/195) reported greater than or equal to 2 sexual partners and 17% (31/186) consistently used condoms in the preceding 12months. 8.2% (16/197) had chlamydia and 0.5% (1/197) gonorrhoea on testing. At recruitment 196 participants consented to NHS numbers being obtained and used to access medical records; 197 participants agreed to 3-month follow-up. We have been able to contact similar to 50% of participants for follow-up.DiscussionMost women consented to NHS number and medical record access. This is important for investigating long-term sequelae of STIs. Fewer women took part in follow-up than agreed at recruitment. It is important to understand the reasons for this.</abstract><doi>10.1136/sextrans-2012-050601c.41</doi></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1472-3263 |
| ispartof | Sexually transmitted infections, 2012-06, Vol.88 (Suppl 1), p.A23-A23 |
| issn | 1472-3263 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1551637856 |
| source | BMJ Journals - NESLi2 |
| subjects | Chlamydia Mycoplasma genitalium |
| title | P41Women's health study of Mycoplasma genitalium: a feasibility study |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T17%3A30%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=P41Women's%20health%20study%20of%20Mycoplasma%20genitalium:%20a%20feasibility%20study&rft.jtitle=Sexually%20transmitted%20infections&rft.au=Dave,%20S&rft.date=2012-06-01&rft.volume=88&rft.issue=Suppl%201&rft.spage=A23&rft.epage=A23&rft.pages=A23-A23&rft.issn=1472-3263&rft_id=info:doi/10.1136/sextrans-2012-050601c.41&rft_dat=%3Cproquest%3E1551637856%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1551637856&rft_id=info:pmid/&rfr_iscdi=true |